Randox Laboratories-US, Ltd. Advanced Chemilumensence Multi-drug panel with Quant results in blood for 29 drugs
The Randox EV4516 is part of the Evidence Series, utilizing advanced chemiluminescence technology for the simultaneous detection and quantification of 29 drugs in blood samples. This multi-drug panel is designed for high-throughput laboratories, offering rapid, sensitive, and specific results. The system automates sample processing and analysis, reducing manual intervention and improving workflow efficiency. The EV4516 panel covers a comprehensive range of drugs of abuse and therapeutic drugs, providing quantitative results that support clinical and forensic toxicology applications. The assay is validated for use with the Evidence Analyzer platform, ensuring reliable and reproducible performance.